1. The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma.
   Danica Sims et al, 2020, Cancers (Basel) CrossRef
2. Molecular mechanisms underpinning sarcomas and implications for current and future therapy
   Victoria Damerell et al, 2021, Sig Transduct Target Ther CrossRef
3. Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas
   Udit Parekh et al, 2021, iScience CrossRef
4. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells
   Maria T. Löblein et al, 2021, IJMS CrossRef
5. The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells
   Victoria Damerell et al, 2022, Front. Oncol. CrossRef
6. Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment
   Irene Marchesi et al, 2022, IJMS CrossRef
7. Proviral ALV-LTR Sequence Is Essential for Continued Proliferation of the ALV-Transformed B Cell Line
   Swagata Roy et al, 2022, IJMS CrossRef
8. c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer
   Martina Lepore Signorile et al, 2022, Cancers CrossRef
9. Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining
   Xiaohui Zhan et al, 2023, Front. Oncol. CrossRef
10. Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1
    Byung Chull An et al, 2023, IJMS CrossRef
11. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest
    Agata Kubickova et al, 2023, IJMS CrossRef